Barry Callebaut has been given a neutral recommendation by UBS, with a target price of CHF 1,590, indicating a potential growth of 28%. The company may experience challenges in terms of volumes and cash flow in the short term.
Looking ahead to 2024-25, Barry Callebaut anticipates stable volumes despite difficult market conditions, and expects double-digit growth in recurring EBIT when measured in local currencies. It is important for investors to carefully consider these insights, given the complexity of the market landscape.